A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

However, the growing recognition of the unique properties of gamma delta T cells, particularly their ability to recognize a broad range of antigens in an MHC-independent manner, has sparked ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including ...

A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...

Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...